Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01215045 · ClinicalTrials.gov registry record
Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 17
- Enrollment target
NCT01215045: Completed study, sponsored by Alcon Research.
NCT01215045 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01215045 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Determine the clinical visual outcomes following bilateral implantation of the AcrySof ReSTOR Aspheric Intraocular Lens (IOL) and to demonstrate what percentage of the subjects obtain spectacle freedom.
Interventions
- DEVICE AcrySof ReSTOR Aspheric +4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-05 |
What the finished NCT01215045 record still lists
NCT01215045 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which AcrySof ReSTOR Aspheric +4 is the first listed.
NCT01215045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01215045 about?
NCT01215045 is a clinical study titled "Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4". Determine the clinical visual outcomes following bilateral implantation of the AcrySof ReSTOR Aspheric Intraocular Lens (IOL) and to demonstrate what percentage of the subjects obtain spectacle freedom.
What is the current status of trial NCT01215045?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2007-06. Estimated completion is 2008-05.
What interventions are being tested in trial NCT01215045?
The interventions under investigation include: AcrySof ReSTOR Aspheric +4 (DEVICE).
Who is sponsoring clinical trial NCT01215045?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia